A new GAO report finds FDA’s regulatory responsibilities expanded substantially between fiscal years 2008 and 2024, and now it faces workforce reductions and organizational restructuring that could further strain its oversight capacity.
FDA warns Abbott Diabetes Care about Quality System violations in its production of glucose monitoring systems at a facility in Alameda, CA.
A new GAO report finds FDA’s regulatory responsibilities expanded substantially between fiscal years 2008 and 2024, and now it faces workforce reductions and organizational restructuring that could further strain its oversight capacity.
FDA warns Abbott Diabetes Care about Quality System violations in its production of glucose monitoring systems at a facility in Alameda, CA.
Former CDRH branch chief Morris Waxler, who was involved in the original approval of laser eye surgery (LASIK) and later a prominent critic of the procedure, dies at the age of 88 due to a stroke.
An FDA-authored journal article signals a supportive but cautious regulatory posture toward the development of chimeric antigen receptor T-cell therapies for autoimmune and rheumatic diseases.
